Cybin (HELP) Other Non-Current Liabilities (2021 - 2025)

Cybin's (HELP) quarterly Other Non-Current Liabilities came in at $19.2 million in Q3 2025, down 5.11% YoY from $20.2 million in Q3 2024, and little changed on a QoQ basis from $19.2 million in Q2 2025.

Cybin (HELP) Other Non-Current Liabilities (2021 - 2025) Analysis & Trends

Cybin (HELP) has 5 years of Other Non-Current Liabilities data on file, last reported at $19.2 million in Q3 2025.

  • Quarterly Other Non-Current Liabilities fell 5.11% year-over-year to $19.2 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $19.2 million (down 5.11% YoY) and the FY2024 annual result came in at $19.0 million, changed N/A from the prior year.
  • Other Non-Current Liabilities steadied at $19.2 million in Q3 2025, from $19.2 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $23.6 million in Q4 2023 to a low of $8.0 million in Q4 2022.
  • A 5-year average of $14.1 million and a median of $10.7 million in 2023 frame the typical range for Other Non-Current Liabilities.
  • Annual changes were most pronounced in 2023 — Other Non-Current Liabilities surged 194.72% — and 2024, when it dropped 16.33%.
  • Tracing HELP's Other Non-Current Liabilities over 5 years: stood at $9.2 million in 2021, then declined by 13.0% to $8.0 million in 2022, then surged by 194.72% to $23.6 million in 2023, then dropped by 16.33% to $19.8 million in 2024, then slipped by 2.83% to $19.2 million in 2025.
  • The last three Other Non-Current Liabilities figures came in at $19.2 million (Q3 2025), $19.2 million (Q2 2025), and $19.8 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Cybin 417.29 Mn 417.29 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 19.19 Mn
Jun 30, 2025 19.19 Mn
Dec 31, 2024 19.75 Mn
Sep 30, 2024 20.23 Mn
Jun 30, 2024 18.75 Mn
Mar 31, 2024 19.03 Mn
Dec 31, 2023 23.61 Mn
Sep 30, 2023 10.68 Mn
Jun 30, 2023 8.09 Mn
Dec 31, 2022 8.01 Mn
Sep 30, 2022 8.64 Mn
Dec 31, 2021 9.21 Mn
Sep 30, 2021 9.29 Mn
Jun 30, 2021 9.13 Mn
Mar 31, 2021 8.82 Mn